Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Pathologic Complete Response × Surgical Procedures, Operative × 1 year × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 16 Breast Neoplasms 10 Sarcoma 9 Neoplasms 8 Glioblastoma 8 Stomach Neoplasms 7 Squamous Cell Carcinoma of Head and Neck 7 Esophageal Neoplasms 7 Rectal Neoplasms 6 Brain Neoplasms 6 Urinary Bladder Neoplasms 5 Carcinoma, Hepatocellular 5 Recurrence 4 Prostatic Neoplasms 4 Oropharyngeal Neoplasms 4 Neoplasm Metastasis 4 Lung Neoplasms 4 Hypopharyngeal Neoplasms 4 Glioma 4 Colonic Neoplasms 4 Thyroid Neoplasms 3 Pancreatic Neoplasms 3 Mouth Neoplasms 3 Melanoma 3 Laryngeal Neoplasms 3 Head and Neck Neoplasms 3 Colorectal Neoplasms 3 Uterine Cervical Neoplasms 2 Triple Negative Breast Neoplasms 2 Skin Neoplasms 2

Interventions

Carboplatin 4 pembrolizumab 3 Paclitaxel 3 Capecitabine 3 Azacitidine 3 venetoclax 2 pertuzumab 2 olaparib 2 durvalumab 2 Trastuzumab 2 Standard of Care 2 Oxaliplatin 2 Observation 2 Irinotecan 2 Immunotherapy 2 Immune Checkpoint Inhibitors 2 Chemoradiotherapy 2 zanidatamab 1 veliparib 1 tucatinib 1 trilaciclib 1 trebananib 1 trastuzumab duocarmazine 1 tislelizumab 1 tegafur-gimeracil-oteracil 1 taxane 1 talazoparib 1 tagraxofusp 1 sarilumab 1 sargramostim 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡